Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 7/20 | 0.65 |
| ▸ | MAPT | P10636 | 6/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 4/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.65 |
| ▸ | NPC1 | O15118 | 3/20 | 0.65 |
| ▸ | BLM | P54132 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.65 |
| ▸ | RELA | Q04206 | 1/20 | 0.65 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.65 |
| ▸ | MASP2 | O00187 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL979497 | 1.00 | HCAR2 (0.74) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL7142763 | 1.00 | HCAR2 (0.74) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL28993560 | 0.88 | HCAR2 (0.65) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL28360825 | 0.86 | KMT2A (0.68) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL11701260 | 0.86 | MASP2 (0.77) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL11701268 | 0.86 | MASP2 (0.77) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL11653185 | 0.85 | HCAR2 (0.61) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL11653187 | 0.85 | HCAR2 (0.61) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL2561722 | 0.85 | HCAR2 (1.00) | HCAR2POLBMAPTKMT2AMEN1 | |
| SCHEMBL125125 | 0.85 | HCAR2 (1.00) | HCAR2POLBMAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122047026-A | Constant/unsteady hydrodynamic performance simulation method based on propeller modeling of ship propeller shaft system | 上海交通大学 | 2026-05-15 | — | — | CN | claimed |
| CN-121582676-A | Deep learning-based power transmission corridor overhead line fastener corrosion detection method | 广东工业大学 | 2026-02-27 | — | — | CN | claimed |
| CN-119760502-A | Automatic driving road side collaborative sensing method based on variability implicit feature alignment | 长沙理工大学 | 2025-04-04 | — | — | CN | claimed |
| CN-117243587-B | Sleep time extraction method for household health monitoring radar | 北京理工雷科电子信息技术有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118608359-A | Method for identifying and predicting key influence factors of departure flight sliding time | 中国电子科技集团公司第二十八研究所 | 2024-09-06 | — | — | CN | claimed |
| CN-117243587-A | Sleep time extraction method for household health monitoring radar | 北京理工雷科电子信息技术有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-115197891-B | Extraction method of exosomes | 广州惠善医疗技术有限公司 | 2023-07-25 | — | — | CN | claimed |
| EP-4162150-A1 | AUTOMATED ELECTRIC SUBMERSIBLE PUMP (ESP) FAILURE ANALYSIS | Services Pétroliers Schlumberger (FR) | 2023-04-12 | — | — | EP | claimed |
| CN-115448907-A | Compound for treating peptic ulcer, intermediate and preparation method | 赛隆药业集团股份有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-115197891-A | Method for extracting exosome | 广州惠善医疗技术有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114459052-B | Coal-fired boiler NOx emission optimization method and device based on improved SSA | 东北电力大学 | 2022-09-09 | — | — | CN | claimed |
| CN-114464266-B | Pulverized coal boiler NOx emission prediction method and device based on improved SSA-GPR | 东北电力大学 | 2022-08-02 | — | — | CN | claimed |
| CN-109613435-B | Method and system for detecting voltage acquisition abnormity caused by non-self fault of battery | 常州普莱德新能源电池科技有限公司 | 2022-07-05 | — | — | CN | claimed |
| WO-2026099756-A1 | PRESSURE MANAGEMENT UNIT OF THE ANNULUS OF AN OIL WELL AND CONTROL METHOD FOR PRESSURE REGULATION | SINERGIA S.P.A. (IT) | 2026-05-15 | — | — | WO | disclosed |
| CN-122047026-A | Constant/unsteady hydrodynamic performance simulation method based on propeller modeling of ship propeller shaft system | 上海交通大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-120536605-B | Primer system for rapidly detecting pinellia ternate bacterial pathogens and detection method and application thereof | 湖北省农业科学院中药材研究所 | 2026-03-20 | — | — | CN | disclosed |
| US-6906105-B2 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | BOWEN J PHILLIP (US) | 2005-06-14 | — | — | US | disclosed |
| US-20030027830-A1 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2003-02-06 | — | — | US | disclosed |
| US-6462075-B1 | USE OF CHALCONE AND ITS DERIVATIVES AS ANTITUMOR/ANTICANCER AGENTS AND TO TREAT A NUMBER OF CONDITIONS OR DISEASE STATES IN WHICH ANGIOGENESIS IS A FACTOR INCLUDING PSORIASIS, ACNE, ROSACEA, WARTS, ECZEMA, HEMANGIOMAS AND LYMPHANGIOGENESIS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2002-10-08 | — | — | US | disclosed |
| US-20020040029-A1 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | BOWEN, J. PHILLIP | 2002-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040029-A1 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | FLT1, FLT4, VEGFA | HCAR2 201/4885POLB 2779/4885MAPT 1111/4885 |
| US-20030027830-A1 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | FLT1, VEGFA, FLT4 | HCAR2 334/4885POLB 1937/4885MAPT 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.